HDAC9 and hematopoietic and lymphoid system neoplasm: On the other hand, the ability of valproic acid to hyperacetylate H3 and H4 histones and to inhibit HDAC has been also demonstrated in the peripheral blood of patients with hematological neoplasms [10], [9].